Form 4: NeueHealth Chief Accounting Officer Reports Stock Transaction

Jeffrey J. Scherman, Chief Accounting Officer of NeueHealth, reports a transaction involving restricted stock units vesting on March 6, 2024.

Summary

• On March 6, 2024, Jeffrey J. Scherman, the Chief Accounting Officer of NeueHealth, engaged in a transaction involving the vesting of restricted stock units.
• A total of 2,491 restricted stock units vested, representing a contingent right to receive an equivalent number of shares of NeueHealth's common stock.
• Following the reported transaction, Scherman directly owns 4,981 derivative securities.
• The restricted stock units vest in three equal annual installments beginning on March 6, 2024.
• After the transaction, Scherman beneficially owns 81,911 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing, reporting a standard transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the holdings and transactions of company insiders.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects the ongoing compensation and equity ownership of a key executive.

Key Dates